Frequently Asked Questions

Invited participants represent a wide range of professionals and individuals involved with the local response to novel H1N1 influenza. Invitees include: hospital officials, physicians, pharmacists, local public health departments, elected officials, emergency management officials, independent school district officials, and representatives from the Department of State Health Services.

Thirty-one individuals have been invited to attend each focus group. An additional five individuals from the Department of State Health Services Health Service Region have also been invited to attend.

No. Participation is by invitation only. If an invited participant is unable to attend, he or she may identify an alternate to attend in his or place. If that is the case, the alternate will be provided an invitation code in which to register. All participants - either invited or an alternate - must register to attend.

If you were not invited to attend or you were unable to attend there are several options in which you can provide feedback to be considered during the after action process. (1) If you work at an organization or agency in which a person has been invited to attend, we suggest you meet with that person before the focus group to share your concerns. The topics that will be discussed at the focus group include: (a) antiviral medication allocation and distribution; (b) vaccine allocation and distribution; (c) communication, media campaigns, and public information; and (d) local / regional response issues. (2) We have developed an online feedback mechanism in which you can provide written comments.

Topics are determined by input from DSHS and from invited participants. Invited participants were asked to complete an online survey to indicate topics and subtopics of interest. DSHS program, technical, and executive staff have also provided input.

Yes. Following this meeting, a summary document of 2-3 pages will be created outlining the major points of discussion at each focus group. The document will be made available in PDF on this web site. Please come back here to download the document. (Please note: Due to the travel schedule there may be a delay of several days in completing and posting the document.)

This process is currently being developed. More information on the release of the final after action report will be posted on this website when it is avaialble (likley date for more information: Mid-May, 2010)

Please contact The Litaker Group at H1N1@litakergroup.com. By using this address, your email be routed to several staff members at once, allowing a quicker response from the first available free staff member.

Please contact us at H1N1@litakergroup.com.

Our preferred method of contact is at H1N1@litakergroup.com. By using this address, your email be routed to several staff members at once, allowing a quicker response from the first available free staff member. However, there may be times when you have specific questions and are not sure who to contact. The table below provides some examples.

Reason for Contacting	Contact Method
I need to send a substitute in my place.	Please send us your contact information and the contact details of the person you want to send in your place to H1N1@litakergroup.com We will provide a response within one business day.
I cannot attend and do not have a substitute.	Please let us know you are unable to attend by emailing us at H1N1@litakergroup.com
I need to fax information and input to the AAR collection team	Please send us a fax to (512) 402-5580
I need to speak to someone regarding my registration or about this project	Our preference is for you to email us with your name and phone number; we will return your call. Please email us at H1N1@litakergroup.com
I have tried to email you and have not received a response and it is urgent that I speak with someone on the AAR collection team	Please contact Dr. John R. Litaker on his cell phone at (512) 633-5948 or by email at jlitaker@litakergroup.com.